Vandetanib with FOLFIRI in patients with advanced colorectal adenocarcinoma: results from an open-label, multicentre Phase I study
Cancer chemotherapy and pharmacology(2009)
摘要
The safety and tolerability of vandetanib (ZACTIMA™; ZD6474) plus FOLFIRI was investigated in patients with advanced colorectal cancer (CRC).
更多查看译文
关键词
Vandetanib,FOLFIRI,Colorectal cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络